Verum Partners LLC

Position in LLY — ELI LILLY & Co

CIK 1958984 CHARLOTTE, NC

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$4,455,882

+$1,129,994 QoQ

Shares Held

3,715

+2.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

3.96%

of 13F equity value

Holder Rank

#1,803

of 4,605 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verum Partners LLC holds $8,397,946 across 6 Drug Manufacturers - General names. LLY ranks #1 (53.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,715	$4,455,882
2	JNJ	Johnson & Johnson	6,156	$1,563,439
3	ABBV	AbbVie Inc.	3,851	$969,065
4	MRK	Merck & Co., Inc.	5,758	$739,903
5	AMGN	Amgen Inc	1,290	$467,134
6	GILD	Gilead Sciences, Inc.	1,603	$202,523

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,455,882	3,715	+2.7%	Shares	Sole	2026-07-22
2026-03-31	$3,325,888	3,616	-5.8%	Shares	Sole	2026-04-15
2025-12-31	$4,123,547	3,837	-8.2%	Shares	Sole	2026-01-14
2025-09-30	$3,190,866	4,182	+0.2%	Shares	Sole	2025-11-12
2025-06-30	$3,253,758	4,174	+487.1%	Shares	Sole	2025-07-15
2025-03-31	$587,222	711	+4.1%	Shares	Sole	2025-04-11
2024-12-31	$527,276	683	-8.7%	Shares	Sole	2025-01-17
2024-09-30	$662,683	748	+2.3%	Shares	Sole	2024-10-16
2024-06-30	$661,832	731	+1.5%	Shares	Sole	2024-07-15
2024-03-31	$560,131	720	-2.7%	Shares	Sole	2024-04-18
2023-12-31	$431,360	740	-2.0%	Shares	Sole	2024-01-18
2023-09-30	$405,533	755	+46.0%	Shares	Sole	2023-10-10
2023-06-30	$242,462	517	-17.0%	Shares	Sole	2023-07-24
2022-12-31	$227,918	623	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.